Johnson & Johnson (JNJ)
NYSE: JNJ
· Real-Time Price · USD
188.64
2.66 (1.43%)
At close: Oct 03, 2025, 3:59 PM
188.76
0.06%
After-hours: Oct 03, 2025, 07:57 PM EDT
1.43% (1D)
| Bid | 188.64 |
| Market Cap | 454.31B |
| Revenue (ttm) | 90.63B |
| Net Income (ttm) | 22.66B |
| EPS (ttm) | 9.67 |
| PE Ratio (ttm) | 19.51 |
| Forward PE | 16.35 |
| Analyst | Buy |
| Dividends | $6.32 |
| Ask | 189.2 |
| Volume | 6,759,681 |
| Avg. Volume (20D) | 8,638,552 |
| Open | 187.06 |
| Previous Close | 185.98 |
| Day's Range | 186.91 - 189.78 |
| 52-Week Range | 140.68 - 189.78 |
| Beta | 0.39 |
| Ex-Dividend Date | Aug 26, 2025 |
Analyst Forecast
According to 0 analyst ratings, the average rating for JNJ stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsJohnson & Johnson is scheduled to release its earnings on
Oct 14, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 days ago
Johnson & Johnson shares are trading higher after ...
Unlock content with
Pro Subscription
1 month ago
-0.49%
Shares of vaccine companies are trading lower following a Daily Beast report suggesting that President Trump and Health and Human Services Robert F. Kennedy, Jr. will ban Covid-19 vaccines "within months." Also, a report suggested that a Covid-19 vaccine skeptic will lead the Covid-19 immunization task force.
